Cargando…
An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors
BACKGROUND: Epithelial ovarian carcinomas encompass a heterogeneous group of diseases with a poor 5-year survival rate. Serous carcinoma is the most common type. Most FDA-approved serum tumor markers are glycoproteins. These glycoproteins on cell surface or shed into the bloodstream could serve as t...
Autores principales: | Li, Qing Kay, Shah, Punit, Tian, Yuan, Hu, Yingwei, Roden, Richard B. S., Zhang, Hui, Chan, Daniel W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424371/ https://www.ncbi.nlm.nih.gov/pubmed/28491011 http://dx.doi.org/10.1186/s12014-017-9152-2 |
Ejemplares similares
-
Targeted glycoproteomic identification of cancer cell glycosylation
por: Powlesland, Alex S, et al.
Publicado: (2009) -
Integrative glycoproteomics reveals protein N-glycosylation aberrations and glycoproteomic network alterations in Alzheimer’s disease
por: Zhang, Qi, et al.
Publicado: (2020) -
Integrated proteomic and N-glycoproteomic analyses of doxorubicin sensitive and resistant ovarian cancer cells reveal glycoprotein alteration in protein abundance and glycosylation
por: Ji, Yanlong, et al.
Publicado: (2017) -
Integrated GlycoProteome Analyzer (I-GPA) for Automated Identification and Quantitation of Site-Specific N-Glycosylation
por: Park, Gun Wook, et al.
Publicado: (2016) -
Precision Glycoproteomics Reveals Distinctive N-Glycosylation in Human Spermatozoa
por: Xin, Miaomiao, et al.
Publicado: (2022)